SSC
ONC icon

Syverson Strege & Co’s BeOne Medicines Ltd ONC Stock Holding History

Syverson Strege & Co’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4
Closed -$862 – 647
2023
Q1 		$862 Buy
+4
New +$959 ﹤0.01% 614

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Syverson Strege & Co's ONC Position: Q2 2023 in Review

Syverson Strege & Co sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 4 shares — an estimated $862 sold.

Syverson Strege & Co first reported a position in ONC in Q1 2023 and held it in 1 quarter. The position peaked at $862 in Q1 2023. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

  • Syverson Strege & Co reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 4 BeOne Medicines Ltd shares in Q2 2023, an estimated $862.
  • Syverson Strege & Co first reported a position in BeOne Medicines Ltd in Q1 2023 and held it in 1 quarter.
  • Syverson Strege & Co's BeOne Medicines Ltd position peaked at $862 in Q1 2023.
  • 208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.